Fresenius Medical Care AGXETR: FME

Release of a capital market information

· Issued by Fresenius Medical Care AG via EQS

Summary by 6ix AI

Fresenius Medical Care AG bought back 849,575 of its own shares from October 12, 2026 to October 16, 2026 (each inclusive), as part of the first tranche, or stage, of its share buyback.

Key details

  • A total of 10,935,840 shares has been acquired so far within the first tranche of the share buyback, whose start was disclosed on May 28, 2026.
  • Purchases were made on October 12, 13, 14 and 15, 2026, at daily weighted average prices per venue ranging from EUR 37.8926 to EUR 39.3027 a share.
  • The largest single entries were 200,000 shares on October 13, 2026 at a weighted average price of EUR 38.0939, for EUR 7,618,780.00, and 190,000 shares on October 12, 2026 at EUR 37.9581, for EUR 7,212,039.00.
  • The shares are bought by a credit institution commissioned by Fresenius Medical Care AG.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/fresenius-medical-care-ag-release-of-a-capital-market-information-3

Watch Fresenius Medical Care's latest callFresenius Medical Care (Xetra:FME) Q2 2026 Earnings Call · Replay · Aug 4Read the transcript of Fresenius Medical Care (Xetra:FME) Q2 2026 Earnings Call

EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014
Fresenius Medical Care AG : Release of a capital market information

19.10.2026 / 14:32 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Fresenius Medical Care AG: Share buyback

Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Share buyback – Interim Report

In the period from October 12, 2026 to October 16, 2026 (each inclusive), 849,575 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

DateAcquired shares (number)Weighted average price (in EUR)Transaction volume
(in EUR)		Trading venue
12 October 2026 26,250 37.9573 996,379.13 AQEU
12 October 2026 91,500 37.9524 3,472,644.60 CEUX
12 October 2026 13,500 37.9602 512,462.70 TQEX
12 October 2026 190,000 37.9581 7,212,039.00 XETR
13 October 2026 19,757 38.1060 752,860.24 AQEU
13 October 2026 79,968 38.0865 3,045,701.23 CEUX
13 October 2026 200,000 38.0939 7,618,780.00 XETR
14 October 2026 19,300 37.8926 731,327.18 AQEU
14 October 2026 66,600 37.8976 2,523,980.16 CEUX
14 October 2026 9,300 37.9022 352,490.46 TQEX
14 October 2026 128,400 37.9075 4,867,323.00 XETR
15 October 2026 5,000 39.3027 196,513.50 XETR

A total of 10,935,840 shares has been acquired within the framework of the first tranche of the share buyback.

The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.


19.10.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language: English
Company: Fresenius Medical Care AG
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
LEI Code: 549300CP8NY40UP89Q40

 
End of News EQS News Service

2418158  19.10.2026 CET/CEST

Fresenius Medical Care AG on 6ix

Earlier from Fresenius Medical Care

Later from Fresenius Medical Care

All Fresenius Medical Care news releases